Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06145035 · ClinicalTrials.gov registry record · Phase 2
Single or Repeated Intravenous Administration of umbiliCAl Cord Mesenchymal sTrOmal Cells in Ischemic Cardiomyopathy
A Phase 2 study of Ischemic Heart Disease, sponsored by Roberto Bolli.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 60
- Enrollment target
- 3
- Study locations
NCT06145035 is a Phase 2 study of Ischemic Heart Disease that is actively recruiting participants, run by Roberto Bolli. The registered enrollment target is 60 participants, below the 262-participant average among 14 other Ischemic Heart Disease trials with a reported enrollment target (77% lower). The trial reports 3 study locations across 3 states.
The verdict
NCT06145035, a Phase 2 study of Ischemic Heart Disease, is actively recruiting participants, sponsored by Roberto Bolli.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 60 participants
- Enrollment target
- 3
- Study locations
Study Summary
This is a Phase IIA, randomized, double blind, placebo controlled, multicenter study designed to assess the safety, feasibility, and efficacy of umbilical cord derived mesenchymal stromal cells (UC MSCs), administered intravenously (IV) as a single dose or repeated doses, in patients with ischemic cardiomyopathy (ICM).
Conditions Studied
Interventions
- BIOLOGICAL umbilical cord-derived mesenchymal stromal cells (UC-MSCs)
Study Locations (3)
Florida
- University of Miami Miller School of Medicine - Miami
Kentucky
- University of Louisville School of Medicine, Institute of Molecular Cardiology - Louisville
Texas
- The Texas Heart Institute Houston Texas - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2024-03-04 |
| Est. Completion | 2026-01-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06145035
The ClinicalTrials.gov registry entry for NCT06145035 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 262-participant average among 14 other Ischemic Heart Disease trials with a reported enrollment target (77% lower). The listed sponsor is Roberto Bolli, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Ischemic Heart Disease appearing as the primary indexed condition, and to 1 intervention - of which umbilical cord-derived mesenchymal stromal cells (UC-MSCs) is the first listed.
NCT06145035 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Florida, Kentucky, Texas.
Frequently Asked Questions
What is clinical trial NCT06145035 about?
NCT06145035 is a clinical study titled "Single or Repeated Intravenous Administration of umbiliCAl Cord Mesenchymal sTrOmal Cells in Ischemic Cardiomyopathy". This is a Phase IIA, randomized, double blind, placebo controlled, multicenter study designed to assess the safety, feasibility, and efficacy of umbilical cord derived mesenchymal stromal cells (UC MSCs), administered intravenously (IV) as a single dose or repeated doses, in patients with ischemic c...
What is the current status of trial NCT06145035?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 60 participants. The study started on 2024-03-04. Estimated completion is 2026-01-01.
What conditions does trial NCT06145035 study?
This clinical trial studies the following conditions: Ischemic Heart Disease.
What interventions are being tested in trial NCT06145035?
The interventions under investigation include: umbilical cord-derived mesenchymal stromal cells (UC-MSCs) (BIOLOGICAL).
Who is sponsoring clinical trial NCT06145035?
This trial is sponsored by Roberto Bolli, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06145035 being conducted?
This trial has 3 study locations across Florida, Kentucky, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ischemic Heart Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
AI-Enabled Direct-from-ECG Ejection Fraction (EF) Severity Assessment Using COR ECG Wearable Monitor
RECRUITING
-
Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)
RECRUITING
-
Pulsed Field Ablation for Post-Infarction Ventricular Tachycardia
RECRUITING · NA
-
Use of GeriKit to Better Phenotype Older Adults With Ischemic Heart Disease
RECRUITING · NA
-
Development of CIRC Technologies
RECRUITING
-
A Single Center Diagnostic, Cross-sectional Study of Coronary Microvascular Dysfunction
ACTIVE NOT RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.